Manufacture

How can we ensure we are better prepared to develop new vaccines and treatments for future infectious disease outbreaks?

Claudia Zylberberg explains the importance of ancillary material quality for advancing cell and gene therapies.

A new polio vaccine could help eradicate the disease once and for all.

How are industry and academia collaborating to tackle neglected diseases?

The world’s largest cell and gene CDMO, an exciting new TCR, and the global CAR T picture… We examine what’s going on in advanced medicine.

Gene therapies (including CAR T) could add $45 billion to US healthcare costs over the next five years, a CVS health report finds.

Researcher at the Wyss Institute have developed a biomaterial-based vaccine that reportedly eliminates acute myeloid leukemia.

The small molecule drug development pipeline is booming! And it means new opportunities for CDMOs.

Let’s reduce gene therapy manufacturing costs by optimizing cell lines, improving transfectants, and optimizing downstream purification.

Carlo Toniatti takes us on a journey from the clinic, to academia, to industry, and shares his lessons learned along the way.